Literature DB >> 8961140

Liposomal subunit vaccines: effects of lipid A and aluminum hydroxide on immunogenicity.

R L Richards1, C R Alving, N M Wassef.   

Abstract

Protein and peptide antigens frequently are only slightly immunogenic when utilized alone in vaccines. Formulation of these antigens in a carrier vehicle, particularly when an adjuvant is included, often results in markedly enhanced immune responses. Encapsulation of peptide and protein antigens in liposomes generally results in a relatively slight enhancement of antibody production compared with that observed with the antigen alone. However, when lipid A is included in the liposomes, immunogenicity is markedly increased compared both with antigen alone and with antigen encapsulated in liposomes lacking lipid A. The enhancement of the immune response caused by lipid A is dependent on the liposomal lipid A dose. Aluminum salts, such as aluminum hydroxide and aluminum phosphate, act as adjuvants for some antigens and are used in a variety of human vaccines. When liposomes containing encapsulated protein or peptide antigens were adsorbed with aluminum hydroxide, an enhancement of the antibody response was observed with some antigens, whereas with other antigens the presence of aluminum hydroxide either had no effect or resulted in a diminished antibody response. Immunogenicity of protein and peptide antigens can be enhanced by formulation in liposomes containing lipid A and, depending on the antigen, can be enhanced further by adsorption of the liposomal antigen formulation with aluminum salts.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8961140     DOI: 10.1021/js9601593

Source DB:  PubMed          Journal:  J Pharm Sci        ISSN: 0022-3549            Impact factor:   3.534


  7 in total

1.  Liposomes containing lipid A serve as an adjuvant for induction of antibody and cytotoxic T-cell responses against RTS,S malaria antigen.

Authors:  R L Richards; M Rao; N M Wassef; G M Glenn; S W Rothwell; C R Alving
Journal:  Infect Immun       Date:  1998-06       Impact factor: 3.441

2.  Liposomes containing monophosphoryl lipid A: a potent adjuvant system for inducing antibodies to heroin hapten analogs.

Authors:  Gary R Matyas; Alexander V Mayorov; Kenner C Rice; Arthur E Jacobson; Kejun Cheng; Malliga R Iyer; Fuying Li; Zoltan Beck; Kim D Janda; Carl R Alving
Journal:  Vaccine       Date:  2013-04-23       Impact factor: 3.641

3.  Lipid tucaresol as an adjuvant for methamphetamine vaccine development.

Authors:  K C Collins; J E Schlosburg; J W Lockner; P T Bremer; B A Ellis; K D Janda
Journal:  Chem Commun (Camb)       Date:  2014-04-21       Impact factor: 6.222

4.  All-trans retinoic acid potentiates the antibody response in mice to a lipopeptide antigen adjuvanted with liposomal lipid A.

Authors:  Douglas S Watson; Zhaohua Huang; Francis C Szoka
Journal:  Immunol Cell Biol       Date:  2009-07-14       Impact factor: 5.126

5.  Enhancing nicotine vaccine immunogenicity with liposomes.

Authors:  Jonathan W Lockner; Sam On Ho; Karen C McCague; Su Ming Chiang; Thai Q Do; Gary Fujii; Kim D Janda
Journal:  Bioorg Med Chem Lett       Date:  2012-12-27       Impact factor: 2.823

6.  The effects of a novel adjuvant complex/Eimeria profilin vaccine on the intestinal host immune response against live E. acervulina challenge infection.

Authors:  Sung-Hyen Lee; Hyun S Lillehoj; Seung I Jang; Kyung-Woo Lee; Robert J Yancey; Paul Dominowski
Journal:  Vaccine       Date:  2010-07-15       Impact factor: 3.641

7.  Identification of Molecular Signatures from Different Vaccine Adjuvants in Chicken by Integrative Analysis of Microarray Data.

Authors:  Duk Kyung Kim; Kyeong Hye Won; Seung Hyun Moon; Hak-Kyo Lee
Journal:  Asian-Australas J Anim Sci       Date:  2015-04-06       Impact factor: 2.509

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.